Emcrown Clinical Research

EmcrownContact Us

Our mission is to advance global healthcare and patients well being through excellence in clinical trials.


We are enrolling for the studies listed below. Please Contact us for more details.

  • ALN-AGT01-007: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Adult Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications.
  • EBS-101-TD-301: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Maintenance of Efficacy of Ecopipam in Children, Adolescents and Adults with Tourette’s Disorder.
  • D4325C00010: A Phase III, Randomised, Multicentre, Double-blind Study to Evaluate the Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin Alone in Participants with Chronic Kidney Disease and High Proteinuria.

Contact Emcrown Clinical Research

    Office address 3601 NW Federal Hwy
    Jensen Beach, FL 34957
    Email us admin@emcrownservices.com
    Contact Us Tel: +1 917 226 0207
    Fax: +1 772 382 0808